We performed a retrospective analysis of 74 patients attending the Myositis Clinic at the Royal National Hospital for Rheumatic Disease, Royal United Hospital, Bath, to evaluate cholesterol management and QRISK3 scores, with particular consideration of anti-HMGCR and non-anti-HMGCR subgroups. The gene discussed is HMGCR; the disease is myositis disease.